Sequential Treatments with Tongsai and Bufei Yishen Granules Reduce Inflammation and Improve Pulmonary Function in Acute Exacerbation-Risk Window of Chronic Obstructive Pulmonary Disease in Rats

Table 2

Mortalities of the rats in each group.

Group		Number of deaths	Mortality (%)
Control	8	0	0
COPD	8	1	12.5
AECOPD	8	2	25
TSG/NS	8	0	0
MXF+STL/NS	8	0	0
TSG/BYG	8	0	0
MXF+STL/STL	8	0	0
TSG+MXF+STL/BYG+STL	8	0	0

Note: AE: acute exacerbation; AECOPD: acute exacerbation of chronic obstructive pulmonary disease; BYG: Bufei Yishen Granule; COPD: chronic obstructive pulmonary disease; MXF: moxifloxacin; NS: normal saline; TSG: Tongsai Granule; STL: salbutamol. versus Control group.